Condition
Thrombophilia clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Thrombophilia clinical trials that are recruiting, at sites in 4 countries (most in China (2), United States (1), Netherlands (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Thrombophilia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Risk tool for blood-clotting problems in adolescents and women with PCOS | — | Guangzhou, Guangdong | Recruiting | May 6, 2026 |
| DOACs versus VKAs to prevent repeat clots in low‑risk antiphospholipid syndrome | — | Madrid, Madrid and 1 other locations | Recruiting | Jan 28, 2026 |
| Observational study of blood clotting and bleeding disorders in Chinese patients | — | Beijing, Beijing Municipality and 4 other locations | Recruiting | Dec 11, 2024 |
| Observational study on young adults with ischemic stroke | — | Nijmegen, Gelderland and 5 other locations | Recruiting | May 11, 2023 |
| Long-term observation of non-cancer blood disorders | — | Phoenix, Arizona and 75 other locations | Recruiting | May 21, 2020 |
All recruiting trials (5)
-
Risk tool for blood-clotting problems in adolescents and women with PCOS
This project will try to build a risk model to spot decreased protein C or S and other clotting abnormalities in females aged 14–45 who have PCOS.
-
DOACs versus VKAs to prevent repeat clots in low‑risk antiphospholipid syndrome
This project will see if direct oral anticoagulants (DOACs) work as well and are as safe as vitamin K antagonists (VKAs) to prevent repeat venous clots in adults with low‑risk thrombotic antiphospholipid syndrome.
-
Observational study of blood clotting and bleeding disorders in Chinese patients
This study looks at blood clotting and bleeding problems in Chinese patients to see how common they are and what factors might affect them.
-
Observational study on young adults with ischemic stroke
This study looks at young adults aged 18-50 who have had a stroke to see what causes it and how to better treat and prevent strokes in this age group.
-
Long-term observation of non-cancer blood disorders
This study is tracking people with blood disorders like hemophilia and thrombosis for at least 15 years to see how their conditions change over time and gather useful information for doctors and researchers.
Related topics
Quick answers
How many Thrombophilia clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), United States (1 trial), Netherlands (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.